Maryland 2022 Regular Session

Maryland House Bill HB109

Introduced
1/12/22  
Refer
1/12/22  
Report Pass
3/18/22  
Engrossed
3/21/22  
Refer
3/21/22  
Report Pass
4/7/22  
Enrolled
4/11/22  
Chaptered
5/12/22  

Caption

Maryland Department of Health – System for Newborn Screening – Requirements

Impact

The implementation of HB 109 is expected to enhance the early detection of hereditary and congenital disorders in newborns, leading to timely interventions that can significantly improve health outcomes. By coordinating the testing and follow-up processes, the bill aims to create a standardized approach to newborn screening across Maryland. This coordination is critical in managing public health resources effectively, ensuring that infants receive appropriate care based on their screening results.

Summary

House Bill 109 requires the Maryland Department of Health to implement a newborn screening system that includes screening for each condition listed in the U.S. Department of Health and Human Services' Recommended Uniform Screening Panel. The bill mandates that the Department seek the approval of the State Advisory Council on Hereditary and Congenital Disorders and the Secretary of Health before adding conditions to the screening panel. Additionally, it outlines specific responsibilities related to the reporting and follow-up of test results, ensuring that necessary information is communicated to healthcare providers and families.

Sentiment

The sentiment surrounding HB 109 appears to be positive, particularly among healthcare professionals and advocates for children’s health. Supporters believe that the bill represents an important step toward improving public health by facilitating early diagnosis of potentially severe health issues. However, there may be concerns regarding the administrative capacity of the Department to manage the expanded responsibilities effectively.

Contention

Some points of contention may arise regarding the timeline and process for adding conditions to the newborn screening panel. Specifically, the bill allows up to two years for the Advisory Council to approve new conditions, which may be seen as a delay in necessary health interventions for newborns. Additionally, discussions may focus on the adequacy of funding and resources to implement these heightened screening requirements without compromising the quality of care provided.

Companion Bills

MD SB242

Crossfiled Maryland Department of Health - System for Newborn Screening - Requirements

Previously Filed As

MD SB242

Maryland Department of Health - System for Newborn Screening - Requirements

MD HB96

Health - Newborn Screening Program - Implementation of Testing

MD SB117

Health - Newborn Screening Program - Implementation of Testing

MD HB1254

Newborn screening requirements.

MD H1073

Newborn Screenings

MD SB105

AN ACT relating to newborn and infant screenings.

MD HB374

AN ACT relating to newborn and infant screenings.

MD SB1344

Newborn screening program

MD S0524

Newborn Screenings

MD SB00373

An Act Concerning Newborn Infant Health Screening.

Similar Bills

MD SB242

Maryland Department of Health - System for Newborn Screening - Requirements

MD SB117

Health - Newborn Screening Program - Implementation of Testing

MD HB96

Health - Newborn Screening Program - Implementation of Testing

TX HB740

Relating to newborn screening for critical congenital heart disease and other disorders.

CA AB3224

Local health department workforce assessment.

LA HB200

Provides relative to newborn screening for certain genetic conditions (EN SEE FISC NOTE GF EX See Note)